DR JASON OSBORNE LTD

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10
Legal registered address
EVOLUTION HOUSE ICENI COURT DELFT WAY NORWICH NORFOLK ENGLAND NR6 6BB Copied!

Latest financial results as of 3 September 2025
Current creditors
£1.94k
Shareholders funds
£-2.04k
View full financial accounts

Company number
09784103 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
TOTAL EXEMPTION FULL
Incorporated on
18 September 2015
Accounts

Latest annual accounts were to 30 September 2019

Next annual accounts are due by 30 June 2021

Company financial year end is on 30 September 2025

Confirmation statement

Latest confirmation statement statement dated 17 September 2020

Next statement due by 1 October 2021

Nature of business (SIC)

86220 - Specialists medical practice activities

Latest company documents
DateDescription
29/06/2029 June 2020 30/09/19 TOTAL EXEMPTION FULL

View Document

07/10/197 October 2019 CONFIRMATION STATEMENT MADE ON 17/09/19, WITH UPDATES

View Document

30/09/1930 September 2019 Annual accounts for year ending 30 Sep 2019

View Accounts

29/01/1929 January 2019 30/09/18 TOTAL EXEMPTION FULL

View Document

30/09/1830 September 2018 Annual accounts for year ending 30 Sep 2018

View Accounts

View all company documents
AI-Powered Analysis for DR JASON OSBORNE LTD

Get instant insights with Claude AI. Ask questions like:

  • "Is DR JASON OSBORNE LTD financially stable?"
  • "What are the key risks for lending to this company?"
  • "Show me the director history and red flags"
Set Up AI Assistant

Takes 60 seconds • Works with Claude.ai


More Company Information

AI Company Analysis

Ask Claude AI about DR JASON OSBORNE LTD:


Start Free Setup →

No downloads • 60 second setup


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company